| Recent advances in “smart” delivery systems for extended drug release in cancer therapy RV Kalaydina, K Bajwa, B Qorri, A Decarlo, MR Szewczuk International journal of nanomedicine, 4727-4745, 2018 | 257 | 2018 |
| Non-nutritive sweeteners and their implications on the development of metabolic syndrome I Liauchonak, B Qorri, F Dawoud, Y Riat, MR Szewczuk Nutrients 11 (3), 644, 2019 | 126 | 2019 |
| Therapeutic potential of medicinal marijuana: an educational primer for health care professionals Y Mouhamed, A Vishnyakov, B Qorri, M Sambi, SMS Frank, C Nowierski, ... Drug, healthcare and patient safety, 45-66, 2018 | 94 | 2018 |
| Therapeutic options for metastatic breast cancer M Sambi, B Qorri, W Harless, MR Szewczuk Breast cancer metastasis and drug resistance: challenges and progress, 131-172, 2019 | 38 | 2019 |
| Novel molecular mechanism of aspirin and celecoxib targeting mammalian neuraminidase-1 impedes epidermal growth factor receptor signaling axis and induces apoptosis in … B Qorri, W Harless, MR Szewczuk Drug design, development and therapy, 4149-4167, 2020 | 36 | 2020 |
| Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity M Sambi, S Haq, V Samuel, B Qorri, F Haxho, K Hill, W Harless, ... Breast Cancer: Targets and Therapy, 85-93, 2017 | 35 | 2017 |
| Agonist-biased signaling via matrix metalloproteinase-9 promotes extracellular matrix remodeling B Qorri, RV Kalaydina, A Velickovic, Y Kaplya, A Decarlo, MR Szewczuk Cells 7 (9), 117, 2018 | 30 | 2018 |
| Next-generation multimodality of nutrigenomic cancer therapy: Sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K … RB Mokhtari, B Qorri, N Baluch, A Sparaneo, FP Fabrizio, LA Muscarella, ... Oncotarget 12 (15), 1470, 2021 | 21 | 2021 |
| A triple combination of metformin, acetylsalicylic acid, and oseltamivir phosphate impacts tumour spheroid viability and upends chemoresistance in triple-negative breast cancer M Sambi, V Samuel, B Qorri, S Haq, SV Burov, E Markvicheva, W Harless, ... Drug Design, Development and Therapy, 1995-2019, 2020 | 18 | 2020 |
| Next generation of cancer drug repurposing: therapeutic combination of aspirin and oseltamivir phosphate potentiates gemcitabine to disable key survival pathways critical for … B Qorri, RB Mokhtari, WW Harless, MR Szewczuk Cancers 14 (6), 1374, 2022 | 17 | 2022 |
| The next-generation of combination cancer immunotherapy: Epigenetic immunomodulators transmogrify immune training to enhance immunotherapy RB Mokhtari, M Sambi, B Qorri, N Baluch, N Ashayeri, S Kumar, ... Cancers 13 (14), 3596, 2021 | 17 | 2021 |
| Using machine intelligence to uncover Alzheimers disease progression heterogeneity B Qorri, M Tsay, A Agrawal, R Au, J Geraci Exploration of Medicine 1 (6), 377-395, 2020 | 16 | 2020 |
| The biased G-protein-coupled receptor agonism bridges the gap between the insulin receptor and the metabolic syndrome I Liauchonak, F Dawoud, Y Riat, B Qorri, M Sambi, J Jain, RV Kalaydina, ... International Journal of Molecular Sciences 19 (2), 575, 2018 | 14 | 2018 |
| 3d multicellular stem-like human breast tumor spheroids enhance tumorigenicity of orthotopic xenografts in athymic nude rat model RB Mokhtari, B Qorri, M Sambi, N Baluch, S Kumar, B Das, MR Szewczuk, ... Cancers 13 (11), 2784, 2021 | 12 | 2021 |
| Drug delivery systems in cancer therapy B Qorri, A DeCarlo, M Mellon, MR Szewczuk Drug Delivery Devices and Therapeutic Systems, 423-454, 2021 | 12 | 2021 |
| The crucial role of primary care providers in the long-term follow-up of adult survivors of childhood cancer J Jain, B Qorri, MR Szewczuk Cancer Management and Research, 3411-3418, 2019 | 10 | 2019 |
| Repositioning of old drugs for novel cancer therapies: continuous therapeutic perfusion of aspirin and oseltamivir phosphate with gemcitabine treatment disables tumor … B Qorri, RB Mokhtari, WW Harless, MR Szewczuk Cancers 14 (15), 3595, 2022 | 8 | 2022 |
| Advancements in polymer science:‘smart’drug delivery systems for the treatment of cancer M Sambi, B Qorri, C Malardier-Jugroot, M Szewczuk MOJ Polym. Sci 1, 113-118, 2017 | 8 | 2017 |
| Targeting the tumor microenvironment to overcome resistance to therapy B Qorri, MR Szewczuk Current Applications for Overcoming Resistance to Targeted Therapies, 35-61, 2019 | 6 | 2019 |
| Machine learning hypothesis-generation for patient stratification and target discovery in rare disease: our experience with Open Science in ALS J Geraci, R Bhargava, B Qorri, P Leonchyk, D Cook, M Cook, F Sie, L Pani Frontiers in Computational Neuroscience 17, 1199736, 2024 | 5 | 2024 |